Amphastar Pharmaceuticals, Inc. — Director's Dealing 2019

Jun 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2019-06-12

Reporting Person: Petersen Floyd F. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-12	Common Stock	A	5491	—	Acquired	76642	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-12	Stock Option (right to buy)	$20.03	A	13915	Acquired	2027-06-12	Common Stock (13915)	Direct

Footnotes

F1: The reported shares are represented by restricted stock units, or RSUs, which vest in two equal annual installments beginning on June 12, 2020.

F2: Shares subject to the option vest in two equal annual installments beginning on June 12, 2020.